| Authors: |
Hamilton CA; Gynecologic Oncology Section, Women's Services and the Ochsner Cancer Institute, Ochsner Health, New Orleans, LA, United States of America. Electronic address: chad.hamilton@ochsner.org., Pothuri B; Department of Obstetrics and Gynecology, NYU School of Medicine, New York City, NY, United States of America., Arend RC; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, United States of America., Backes FJ; Division of Gynecologic Oncology, Ohio State University and James Cancer Hospital, Columbus, OH, United States of America., Gehrig PA; Professor and Chief, Division of Gynecologic Oncology, University of North Carolina, Chapel Hill, NC, United States of America., Soliman PT; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Thompson JS; Division of Radiation Oncology, Stephenson Cancer Center, University of Oklahoma, Oklahoma City, OK, United States of America., Urban RR; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Washington School of Medicine, Seattle, WA, United States of America., Burke WM; Department of Obstetrics, Gynecology and Reproductive Medicine, Stony Brook University Cancer Center, Stony Brook, NY, United States of America. |
